Molecular Diagnosis of Hematopoietic and Lymphoid Neoplasms

被引：5
|
作者：
Jevremovic, Dragan [1 ]
Viswanatha, David S. [1 ]
机构：
[1] Mayo Clin, Dept Lab Med & Pathol, Div Hematopathol, Rochester, MN 55905 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2009年 / 23卷 / 04期
关键词：
Gene rearrangements; Clonality; Chromosome translocation; Polymerase chain reaction; Fluorescence in situ hybridization; Minimal residual disease; POLYMERASE-CHAIN-REACTION; MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; B-CELL LYMPHOMA; TIME QUANTITATIVE PCR; ACUTE PROMYELOCYTIC LEUKEMIA; IN-SITU HYBRIDIZATION; HARMONIZING CURRENT METHODOLOGY; CHRONIC LYMPHOCYTIC-LEUKEMIA;
D O I：
10.1016/j.hoc.2009.04.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This chapter summarizes the significance and molecular diagnostic detection of genetic abnormalities commonly associated with hematolymphoid neoplasms. Methodologic aspects of laboratory diagnosis are presented, as well as discussion of multiparameter genotyping of tumors for prognosis and the role of minimal residual disease monitoring in specific neoplasms.
引用
收藏
页码：903 / +
页数：32
相关论文
共 50 条
  • [31] Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
    Christopher Wenzinger
    Eli Williams
    Alejandro A. Gru
    Current Hematologic Malignancy Reports, 2018, 13 : 275 - 288
  • [32] Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
    Wenzinger, Christopher
    Williams, Eli
    Gru, Alejandro A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (04) : 275 - 288
  • [33] MOLECULAR GENETIC FOR THE DIAGNOSIS OF LYMPHOID MALIGNANCIES
    MARIANO, MT
    MERLI, F
    GRANTINI, M
    TAGLIAFICO, E
    SARTI, M
    COLO, A
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1987, 7 (04): : 436 - 438
  • [34] Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report
    Lim, Megan S.
    Bailey, Nathanael G.
    King, Rebecca L.
    Piris, Miguel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (03) : 277 - 301
  • [35] 605.MOLECULAR PHARMACOLOGY AND DRUG RESISTANCE: LYMPHOID NEOPLASMS
    Knight, Kristopher Adrian
    Brown, Harrison C.
    Karpen, Mathew S.
    Spencer, H. Trent
    Doering, Christopher B.
    Raikar, Sunil S.
    BLOOD, 2024, 144 : 4169 - 4170
  • [36] The molecular diagnosis and management of thyroid neoplasms
    Theoharis, Constantine
    Roman, Sanziana
    Sosa, Julie Ann
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (01) : 35 - 41
  • [37] Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
    Loghavi, Sanam
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph D.
    Medeiros, L. Jeffrey
    Naresh, Kikkeri N.
    Nejati, Reza
    Patnaik, Mrinal M.
    MODERN PATHOLOGY, 2024, 37 (02)
  • [38] APPLICATIONS OF ANTIGEN RECEPTOR GENE REARRANGEMENTS TO THE DIAGNOSIS AND CHARACTERIZATION OF LYMPHOID NEOPLASMS
    SKLAR, J
    WEISS, LM
    ANNUAL REVIEW OF MEDICINE, 1988, 39 : 315 - 334
  • [39] Oncogene Amplification as an Incidental Finding in FISH Testing for Gene Rearrangements in Lymphoid Hematopoietic Neoplasms
    Sun, Guoxian
    Montella, Lya
    BLOOD, 2011, 118 (21) : 1072 - 1072
  • [40] A case-control study of hematopoietic and lymphoid neoplasms: The role of work in the chemical industry
    Massoudi, BL
    Talbott, EO
    Day, RD
    Swerdlow, SH
    Marsh, GM
    Kuller, LH
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1997, 31 (01) : 21 - 27
12345